Category
Public Health
9 articles
Ultra-Processed Food Policy in Australia: Closing the Gap
Australia lacks binding regulation of ultra-processed foods despite strong evidence linking NOVA Group 4 consumption to metabolic disease. A policy analysis of labelling reform, marketing restrictions, and international lessons from Chile and the UK.
Vaping Reform Australia 2026: Policy Analysis
Australia's prescription-only vaping model, the 2024 pharmacy supply amendments, enforcement reality, youth uptake data, the harm-reduction debate, and the 2026 policy landscape.
Childhood Obesity in Australia: Why Individual Responsibility Framing Has Failed and What Policy Must Change
One in four Australian children is overweight or obese. A policy analysis of why 'eat less, move more' campaigns fail, and what evidence-based interventions — sugar taxes, advertising bans, food labelling reform, and school food environments — can actually work.
Type 2 Diabetes in Australia: Prevalence, Cost and Policy
Type 2 diabetes Australia statistics: 1.2 million diagnosed, $4.4 billion in annual health expenditure, and deep equity gaps demanding urgent policy reform.
Australia's Public Dental Health Crisis: The Medicare Gap That Harms Millions
Dental health is excluded from Medicare despite overwhelming evidence that oral health is integral to systemic health. Here's the policy case for universal dental coverage, the cost of inaction, and what reform would look like.
Bariatric Surgery Access in Australia: Policy Failures, Equity Gaps, and the Case for Reform
Australia's bariatric surgery system is two-tiered, inequitable, and failing hundreds of thousands of people with severe obesity. A policy analysis of access barriers, public waitlist failures, the economic case for expanded funding, and the role of GLP-1 medications in reshaping the surgical pipeline.
The Obesity Crisis in Australia: What the Evidence Tells Us
Australia faces a serious obesity crisis. This article examines the latest prevalence data, economic burden, and why emerging metabolic science is reshaping the research landscape.
Preventive Health Funding in Australia: The Policy Case for Investment
Australia spends roughly 1.8% of total health expenditure on prevention versus the WHO 5% benchmark. A policy analysis of underinvestment, return on investment evidence, and costed reform proposals for 2026 and beyond.
Metabolic Syndrome in Australia: The Policy Gap Between Evidence and Action
Australia's metabolic syndrome burden is large, growing, and poorly addressed by current Medicare and public health policy. An evidence-based analysis of the gap between what the research shows and what the health system delivers.